A/Prof Bruce Burnett is responsible for overseeing a group of professionals that offer a variety of regulatory and quality services designed to support investigators to ensure they are in full compliance with the regulations governing their preclinical and clinical research. These services include education, regulatory consultation, support for regulatory submissions, quality control/assurance activities, and GMP, GLP, and GCP guidance.
A/Prof Burnett brings over 25 years of experience in the pharmaceutical industry involving research and development, scientific affairs, quality control/assurance, and regulatory affairs. He came to Duke from AlphaVax, a local vaccine biotech company where he served as Vice President of Quality and Regulatory Affairs. He has also held both senior regulatory and quality positions at BiogenIdec, Genetics Institute (Wyeth Pharmaceuticals), and Serono.
A/Prof Burnett received his undergraduate degree in organic chemistry from the University of California, San Diego and his PhD in organic chemistry/biochemistry from MIT working in the laboratory of Nobel Laureate Dr Har Gobind Khorana. He completed an NIH postdoctoral fellowship in genetics at Harvard University and Harvard Medical School.